We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NOMD:NYSENomad Foods Limited analysis

Data as of Oct 4, 2026 - not real-time

Latest price
$10.65
Risk: medium
6/10Medium risk

Summary

Nomad Foods Limited trades at $10.65, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 8.3%. With RSI at 42.5 the momentum picture is neutral, alongside a bullish MACD signal. Watch $10.25 as support and $11.73 as the nearer resistance level.
The shares look undervalued at 10.3 times earnings, though no sector average was available for comparison. Sell-side targets cluster 24.5% above the current quote. Revenue is contracting at 3.1% on a 4.2% profit margin. The 6.39% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 25.3%, a beta of -0.01 and a maximum drawdown of 30.6%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top market events

  • Read Nomad Foods Limited NOMD Q2 FY2026 Q&A earnings call transcript on Yahoo Finance to keep your investing strategy...
  • Nomad Food Limited NOMD rose in premarket trading after the company reported some insider buying action.
  • Brisby's open-market purchase at $12.38 per share comes after stock declined 22% year-to-date, signaling confidence...

Market outlook

Short term

< 1 year

Positive

Model confidence4/104 out of 10

Key factors

  • Trading below the 200-day average of 11.06
  • MACD momentum is positive
  • 30-day price change of -8.3%

Medium term

1–3 years

Positive

Model confidence5/105 out of 10

Key factors

  • Trading below the 200-day average of 11.06
  • Analyst targets imply +24.5% versus the current price
  • MACD momentum is positive

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • Analyst targets imply +24.5% versus the current price
  • Revenue contracting at -3.1%
  • P/E ratio of 10.3

Key metrics

Financial health

Revenue Growth-3.10%
Profit Margin4.19%
P/E Ratio10.3
ROE4.89%
ROA3.76%
Debt/Equity91.84
P/B Ratio0.5
Op. Cash Flow$330.2M
Free Cash Flow$128.3M

Technical analysis

TrendNeutral
RSI42.5
Support$10.25
Resistance$11.73
MA 20$10.83
MA 50$11.44
MA 200$11.06
MACDBullish
VolumeStable
Fear & Greed Index94.09

Valuation

Target Price$13.26
Upside/Downside24.55%
GradeUndervalued
TypeValue
Dividend Yield6.39%

Risk assessment

Beta-0.01
Volatility25.27%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.